Skip to content
10-Q

Quarterly Report

ENDOCYTE INC

0001558370-18-004450

← back to feed
Filed
May 9, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Apr 30, 2018 69.5M sh
Stock Repurchased Q1 2018 · Mar 31, 2018 $104.46K
Stock Repurchased Q1 2018 · Mar 31, 2017 $92.93K
Capex Q1 2018 · Mar 31, 2018 $5.23K
Capex Q1 2018 · Mar 31, 2017 $29.54K
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$7.71M
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$10.48M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $89.83M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $18.56M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $33.66M
Cash And Equivalents Q1 2018 · Dec 31, 2016 $31.23M
Stockholders Equity Q1 2018 · Mar 31, 2018 $171.7M
Stockholders Equity Q1 2018 · Dec 31, 2017 $95.48M
Current Liabilities Q1 2018 · Mar 31, 2018 $4.61M
Current Liabilities Q1 2018 · Dec 31, 2017 $4.55M
Total Liabilities Q1 2018 · Mar 31, 2018 $4.98M
Total Liabilities Q1 2018 · Dec 31, 2017 $5.28M
Current Assets Q1 2018 · Mar 31, 2018 $174.56M
Current Assets Q1 2018 · Dec 31, 2017 $98.57M
Total Assets Q1 2018 · Mar 31, 2018 $176.68M
Total Assets Q1 2018 · Dec 31, 2017 $100.76M
Sga Expense Q1 2018 · Mar 31, 2018 $3.78M
Sga Expense Q1 2018 · Mar 31, 2017 $3.75M
Rd Expense Q1 2018 · Mar 31, 2018 $5.26M
Rd Expense Q1 2018 · Mar 31, 2017 $7.99M
Net Income Q1 2018 · Mar 31, 2018 −$8.6M
Net Income Q1 2018 · Mar 31, 2017 −$11.49M
Operating Income Q1 2018 · Mar 31, 2018 −$9.02M
Operating Income Q1 2018 · Mar 31, 2017 −$11.73M
Revenue Q1 2018 · Mar 31, 2018 $15.86K
Revenue Q1 2018 · Mar 31, 2017 $12.5K